Type III Interferons: Emerging Roles in Autoimmunity

Type III interferons (IFNs) or the lambda IFNs (IFNLs or IFN-λs) are antimicrobial cytokines that play key roles in immune host defense at endothelial and epithelial barriers. IFNLs signal via their heterodimeric receptor, comprised of two subunits, IFNLR1 and interleukin (IL)10Rβ, which defines the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sindhu Manivasagam, Robyn S. Klein
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/30974b42fe614b708565ecd69cff0406
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:30974b42fe614b708565ecd69cff0406
record_format dspace
spelling oai:doaj.org-article:30974b42fe614b708565ecd69cff04062021-12-01T04:24:05ZType III Interferons: Emerging Roles in Autoimmunity1664-322410.3389/fimmu.2021.764062https://doaj.org/article/30974b42fe614b708565ecd69cff04062021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.764062/fullhttps://doaj.org/toc/1664-3224Type III interferons (IFNs) or the lambda IFNs (IFNLs or IFN-λs) are antimicrobial cytokines that play key roles in immune host defense at endothelial and epithelial barriers. IFNLs signal via their heterodimeric receptor, comprised of two subunits, IFNLR1 and interleukin (IL)10Rβ, which defines the cellular specificity of the responses to the cytokines. Recent studies show that IFNL signaling regulates CD4+ T cell differentiation, favoring Th1 cells, which has led to the identification of IFNL as a putative therapeutic target for autoimmune diseases. Here, we summarize the IFNL signaling pathways during antimicrobial immunity, IFNL-mediated immunomodulation of both innate and adaptive immune cells, and induction of autoimmunity.Sindhu ManivasagamSindhu ManivasagamRobyn S. KleinRobyn S. KleinRobyn S. KleinRobyn S. KleinFrontiers Media S.A.articleinterferon lambdaautoimmune diseasesTh1 cellsIFNLRneuroimmunology and neuropathologyImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic interferon lambda
autoimmune diseases
Th1 cells
IFNLR
neuroimmunology and neuropathology
Immunologic diseases. Allergy
RC581-607
spellingShingle interferon lambda
autoimmune diseases
Th1 cells
IFNLR
neuroimmunology and neuropathology
Immunologic diseases. Allergy
RC581-607
Sindhu Manivasagam
Sindhu Manivasagam
Robyn S. Klein
Robyn S. Klein
Robyn S. Klein
Robyn S. Klein
Type III Interferons: Emerging Roles in Autoimmunity
description Type III interferons (IFNs) or the lambda IFNs (IFNLs or IFN-λs) are antimicrobial cytokines that play key roles in immune host defense at endothelial and epithelial barriers. IFNLs signal via their heterodimeric receptor, comprised of two subunits, IFNLR1 and interleukin (IL)10Rβ, which defines the cellular specificity of the responses to the cytokines. Recent studies show that IFNL signaling regulates CD4+ T cell differentiation, favoring Th1 cells, which has led to the identification of IFNL as a putative therapeutic target for autoimmune diseases. Here, we summarize the IFNL signaling pathways during antimicrobial immunity, IFNL-mediated immunomodulation of both innate and adaptive immune cells, and induction of autoimmunity.
format article
author Sindhu Manivasagam
Sindhu Manivasagam
Robyn S. Klein
Robyn S. Klein
Robyn S. Klein
Robyn S. Klein
author_facet Sindhu Manivasagam
Sindhu Manivasagam
Robyn S. Klein
Robyn S. Klein
Robyn S. Klein
Robyn S. Klein
author_sort Sindhu Manivasagam
title Type III Interferons: Emerging Roles in Autoimmunity
title_short Type III Interferons: Emerging Roles in Autoimmunity
title_full Type III Interferons: Emerging Roles in Autoimmunity
title_fullStr Type III Interferons: Emerging Roles in Autoimmunity
title_full_unstemmed Type III Interferons: Emerging Roles in Autoimmunity
title_sort type iii interferons: emerging roles in autoimmunity
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/30974b42fe614b708565ecd69cff0406
work_keys_str_mv AT sindhumanivasagam typeiiiinterferonsemergingrolesinautoimmunity
AT sindhumanivasagam typeiiiinterferonsemergingrolesinautoimmunity
AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity
AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity
AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity
AT robynsklein typeiiiinterferonsemergingrolesinautoimmunity
_version_ 1718405894455164928